Dysregulated transforming growth factor-β in neonatal and adult autoimmune MRL-lpr mice

Journal of Autoimmunity

Volumn 9, Issue 4, 1996, Pages 463-472

  Kreft, Burkhard ^a   Yokoyama, Hitoshi ^a   Naito, Takero ^a   Kelley, Vicki Rubin ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Autoimmune renal disease; MRL lpr mice; TGF

Indexed keywords

COLONY STIMULATING FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ETIOLOGY; FEMALE; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL;

EID: 0030218084     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1996.0063     Document Type: Article

References (45)

1. 1. Border W.A., Okuda S., Languino L.R., Sporn M.B., Ruoslahti E. 1990. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-β1. Nature 346: 371-374
2. 2. Yui M.A., Brisette W.H., Brennan D.C., Wuthrich R.P., Rubin-Kelley V.E. 1991. Increased macrophage colony-stimulating factor in neonatal and adult autoimmune MRL-lpr mice. Am. J. Pathol. 139: 255-261
3. 3. Boswell J.M., Yui M.A., Burt D.W., Kelley V.E. 1988. Increased tumor necrosis factor and IL-1β gene expression in the kidneys of mice with lupus nephritis. J. Immunol 141: 3050-3054
4. 4. Brennan D.C., Yui M.A., Wuthrich R.P., Kelley V.E. 1989. Tumor necrosis factor and IL-1 in New Zealand black/white mice. Enhanced gene expression and acceleration of renal injury. J. Immunol. 143: 3470-3475
5. - lymphocyte during the development of murine autoimmune disease. J. Exp. Med. 172: 1177-1183
6. 6. Tang B., Matsuda T., Akira S., Nagata N., Ikehara S., Hirano T., Kishimoto T. 1991. Age-associated increase in interleukin 6 in MRL/lpr mice. Inter. Immunol. 3: 273-278
7. 7. Yokoyama H., Takabartake T., Takaeda M., Wada T., Naito T., Ikeda S., Goshima S., Takasawa T., Tomosugi N., Kobayashi K., Kida H. 1992. Up-regulated MHC-class II expression and γ-IFN and soluble IL-2R in lupus nephritis. Kidney Int. 42: 755-763
8. 8. Linker-Israeli M., Deans R.J., Wallace D.J., Prehn J., Ozerki-Chen T., Klinenberg J.R. 1991. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J. Immunol. 147: 117-123
9. 9. Altman A., Theofilopoulos A.N., Weinar R., Katz D.H., Dixon F.J. 1981. Analysis of T cell function in autoimmune murine strains. Defects in production of and responsiveness to interleukin 2. J. Exp. Med. 154: 793-808
10. 10. Donnelly R.P., Levine J., Hartwell D.W., Frendl G., Fenton M.J., Beller D.I. 1990. Aberrant regulation of IL-1 expression in macrophages from young autoimmune-prone mice. J. Immunol. 145: 3231-3239
11. 11. Yokoyama H., Kreft B., Kelley V.R. 1995. Biphasic increase in circulating and renal TNF-α in MRL-lpr mice with differing regulatory mechanisms. Kidney Int. 47: 122-130
12. 12. McCarty-Francis N.C., Wahl S.M. 1994. Transforming growth factor-β: a matter of life and death. J. Leukocyte Biol. 55: 401-409
13. 13. Jhappen C., Geiser A.G., Kordon E.C., Bagheri D., Hennighausen L., Roberts A.B., Smith G.H., Merlino G. 1993. Targeting expression of a transforming growth factor-β1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J. 12: 1835-1845
14. 14. Selheyer K., Kickenbach J.R., Rothnagel J.A., Bundman D., Longley M.A., Kreig T., Roche N.S., Roberts A.F., Roop D.R. 1993. Inhibition of skin development by overexpression of transforming growth factor-β1 in the epidermis of transgenic mice. Proc. Natl. Acad. Sci. USA 90: 5237-5241
15. 15. Sanderson N., Nagy P., Muirakami H., Kondaiah P., Roberts A.B., Sporn M.B., Thorgeirsson S.S. 1994. Establishment of a transgenic model for hepatic cirrhosis in mice gearing a fission gene consisting of albumin enhancer/promoter and porcine TGF-β1 cDNA. In Regulation of Liver Gene Expression in Health and Disease. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
16. 16. Shull M.M., Ormsby I., Kier A.B., Pawloski S., Diebold R.J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D., Andnunzia N., Doetschman T. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359: 693-699
17. 17. Kulkarni A.B., Karlsson S. 1993. Transforming growth factor-β1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. Am. J. Pathol. 143: 3-9
18. 18. Kulkarni A.B., Huh C.H., Becker D., Geiser A., Lyght M., Flanders K.C., Roberts A.B., Sporn M.B., Ward J.M., Karlsson S. 1993. Transforming growth factor-β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90: 770-774
19. 19. Santambrogio L., Hochwald G.M., Saxena B., Leu C.H., Marts J.E., Carlino J.A., Ruddle N.H. Palladino M.A., Gold L.I., Thorbecke G.J. 1993. Studies on the mechanisms by which transforming growth factor-β (TGF-β) protects against allergic encephalomyelitis. J. Immunol. 151: 1116-1127
20. 20. Wuthrich R.P., Glimcher L.H., Yui M.A., Jevnikar A.M., Dumas S.E., Kelley V.E. MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int. 37: 783-792
21. 21. Schrader J., Moyer C., Ziltener H.J., Reinisch C.L. 1991. Release of the cytokines colony-stimulating factor-1, granulocyte-macrophage colony stimulating factor, and IL-6 by cloned murine vascular smooth muscle cells. J. Immunol. 146: 3799-3808
22. 22. Chegni N., Flanders K.C. 1992. Presence of transforming growth factor-β and their selective cellular localization in human ovarian tissue of various reproductive stages. Endocrinol. 130: 1707-1715
23. 23. Flanders K.C., Thompson N.L., Cissel D.S., Van Obberghen-Schilling E., Baker C.C., Kass M.E., Ellingsworth L.R., Roberts A.B., Sporn M.B. 1989. Transforming growth factor-β1: histochemical localization with antibodies to different epitopes. J. Cell Biol. 108: 653-660
24. 24. Flanders K.C., Cissel D.S., Mullen L.T., Danielpour D., Sporn M.B., Roberts A.B. 1990. Antibodies to transforming growth factor-β2 peptides: specific detection of TGF-β2 in immunoassays. Growth Factors 3: 45-52
25. 25. Flanders K.C., Ludecke G., Engels S., Cissel D.S., Roberts A.B., Kondaiah P., Lafyatis R., Sporn M.B., Unsicker K. 1991. Localization and actions of transforming growth factor-βs in the embryonic nervous system. Development 1113: 183-191
26. 26. Jennings J.C., Mohan S., Linlhart T.A., Widstrom R., Baylink D.J. 1988. Comparison of the biological actions of TGF-β1 and TGF-β2: Differential activity in endothelial cells. J. Cell Physiol 137: 167-172
27. 27. Danielpour D., Dart L., Flanders K.C., Roberts A.B., Sporn M.B. Immunodetection and quantification of the two forms of transforming growth factor-β (TGF-β1 and TGF-β2) secreted by cells in culture. J. Cell Physiol. 138: 79-86
28. 28. Diaz-Gallo C., Jevnikar A.M., Brennan D.C., Florquin S., Pachoco-Silva A., Kelley V.E. 1992. Autoreactive kidney-infiltrating T-cell clones in murine lupus nephritis. Kidney Int. 42: 851-859
29. 29. Hanawa H., Tsuchida M., Matsumoto Y., Watanabe H., Abo T., Sekikawa H., Kodama M., Zhang S., Izuma T., Shibata A. 1993. Characterization of T cells infiltrating the heart in rats with experimental autoimmune myocarditis. J. Immunol. 150: 5682-5695
30. 30. Waltenberger J., Wanders A., Fellstrom B., Miyazono K., Heldin C.H., Funa K. 1993. Induction of transforming growth factor-β during cardiac allograft rejection. J. Immunol. 151: 1147-1157
31. 31. Okuda S., Languino L.R., Rouslahti E., Border W.A. 1990. Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J. Clin. Invest. 86: 453-462
32. 32. Brandes M.E., Allen J.B., Ogawa Y., Wahl S.M. 1991. Transforming growth factor-β1 suppresses acute and chronic arthritis in experimental animals. J. Clin. Invest. 87: 108-1113
33. 33. Allen J.B., Manthey C.L., Hand A.R., Ohura K., Ellingsworth I., Wahl S.M. 1990. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor-β. J. Exp. Med. 171: 231-247
34. 34. Kuruvilla A.P., Shah R., Hochwald G.M., Liggitt H.D., Palladino M.A., Thorbecke G.J. 1991. Protective effect of transforming growth factor-β1 on experimental autoimmune disease in mice. Proc. Natl. Acad. Sci. USA 88: 2918-2921
35. 35. Racke M.K., Dhib-Jalbu S., Cannella B., Albert P.S., Raine C.S., McFarlin D.E. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β. J. Immunol. 146: 3012-3017
36. 36. Johns L.D., Flanders K.C., Ranges G.E., Sriram S. 1991. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1. J. Immunol. 147: 1872-179
37. 37. Massague J., Cheifetz S., Laiho M., Ralph D.A., Weis F.M.B., Zentella A. 1992. Transforming growth factor-β. Cancer Surg. 12: 81-103
38. 38. Miyazono K., Dijke P., Ichijo H., Heldin C.H. 1993. Receptors for transforming growth factor-β. Adv. Immunol. 35: 181-220
39. 39. Kim S.J., Jeang K.T., Glick A., Sporn M.B., Roberts A.F. 1989. Promoter sequences of the human transforming growth factor-β1 gene responsive to transforming growth factor-β1 auto induction. J. Biol. Chem. 264: 7041-7045
40. 40. Lafyatis R., Lechleider R., Kim S.J., Jakowlew S., Roberts A.B., Sporn M.B. 1990. Structural and functional characterization of the transforming growth factor-β3 promoter: a cAMP responsive element regulates basal and induced transcription. J. Biol. Chem. 265: 19128-19136
41. 41. Noma T., Click A.B., Geiser A.G., O'Reilly M.A., Miller J., Roberts A.B., Sporn M.B. 1991. Molecular cloning and structure of the human transforming growth factor-β2 gene promoter. Growth Factors 4: 247-255
42. 42. Brennan D.C., Jevnikar A.M., Bloom R.D., Brissette W.H., Singer G.G., Rubin Kelley V. 1992. Cultured mesangial cells from autoimmune MRL-lpr mice have decreased secreted and surface M-CSF despite increased circulating and renal expression. Kidney Int. 42: 279-284
43. 43. Jevnikar A.M., Brennan D.C., Singer G.G., Heng J.E., Maslinski W., Wuthrich R.P., Glimscher L.H., Rubin-Kelley V.E. 1991. Stimulated kidney tubular epithelial cells express membrane associated and secreted TNF-α. Kidney Int. 40: 203-211
44. 44. Naito T., Griffiths R.C., Coffman T., Kelley V.E. 1995. Transplant approach establishes: kidneys are responsible for serum CSF-1, but requires a stimulus in MRL-lpr mice. Kidney Int. 49: 67-74
45. 45. Suda T., Takahashi T., Golstein P., Nagata S. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169-1178